Filing Details
- Accession Number:
- 0000884905-12-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-23 15:30:47
- Reporting Period:
- 2012-02-21
- Filing Date:
- 2012-02-23
- Accepted Time:
- 2012-02-23 15:30:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
884905 | Praxair Inc | PX | Industrial Inorganic Chemicals (2810) | 061249050 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190780 | S Ricardo Malfitano | 39 Old Ridgebury Road Danbury CT 06810-5113 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-02-21 | 50,501 | $53.98 | 86,384 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-21 | 50,501 | $110.03 | 35,883 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-02-21 | 18,447 | $61.47 | 54,330 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-21 | 18,447 | $110.01 | 35,883 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-02-22 | 23,556 | $53.98 | 59,439 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-22 | 23,556 | $110.01 | 35,883 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-02-22 | 10,110 | $61.47 | 45,993 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-22 | 10,110 | $110.01 | 35,883 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2012-02-21 | 50,501 | $0.00 | 50,501 | $53.98 |
Common Stock | Stock Option (right to buy) | Disposition | 2012-02-21 | 18,447 | $0.00 | 18,447 | $61.47 |
Common Stock | Stock Option (right to buy) | Disposition | 2012-02-22 | 23,556 | $0.00 | 23,556 | $53.98 |
Common Stock | Stock Option (right to buy) | Disposition | 2012-02-22 | 10,110 | $0.00 | 10,110 | $61.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
23,556 | 2007-02-28 | 2016-02-29 | No | 4 | M | Direct |
54,421 | 2008-02-27 | 2017-02-27 | No | 4 | M | Direct |
0 | 2007-02-28 | 2016-02-27 | No | 4 | M | Direct |
44,311 | 2008-02-27 | 2017-02-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,746 | Indirect | 401(k) |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $83.89 | 2009-02-26 | 2018-02-26 | 54,800 | 54,800 | Direct |
Common Stock | Stock Option (right to buy) | $60.92 | 2010-02-24 | 2019-02-24 | 83,900 | 83,900 | Direct |
Common Stock | Stock Option (right to buy) | $76.16 | 2011-02-23 | 2020-02-23 | 53,720 | 53,720 | Direct |
Common Stock | Stock Option (right to buy) | $97.84 | 2012-02-22 | 2021-02-22 | 57,720 | 57,720 | Direct |
Common Stock | Deferred Stock | $0.00 | 11,336 | 11,336 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2018-02-26 | 54,800 | 54,800 | Direct |
2019-02-24 | 83,900 | 83,900 | Direct |
2020-02-23 | 53,720 | 53,720 | Direct |
2021-02-22 | 57,720 | 57,720 | Direct |
11,336 | 11,336 | Direct |
Footnotes
- This total includes shares previously acquired through automatic dividend reinvestment under the Praxair Dividend Reinvestment and Stock Purchase Plan.
- The $110.026 price reported is the weighted average sale price. The sale prices ranged from $110.00 to $110.328 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- The $110.006 price reported is the weighted average sale price. The sale prices ranged from $110.00 to $110.095 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- The $110.011 price reported is the weighted average sale price. The sale prices ranged from $110.00 to $110.20 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- The $110.007 price reported is the weighted average sale price. The sale prices ranged from $110.00 to $110.26 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- This option vests over three years in three consecutive equal annual installments beginning on February 24, 2010.
- This option vests over three years in three consecutive equal annual installments beginning on February 23, 2011.
- This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
- Conversion to Praxair Common Stock is on a 1-for-1 basis.
- Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.